DUSA Pharmaceuticals
For Physicians  |  For Investors  |  For Pharmacists  |  Contact Us
HomeProductsAbout DUSANews/Events
Press Releases
  • June 19, 2008
  • May 16, 2008
  • May 7, 2008
  • May 7, 2008
  • May 2, 2008
  • May 1, 2008
  • March 31, 2008
  • April 21, 2008
  • March 6, 2008
  • March 4, 2008 Fourth Quarter and Full Year 2007 Conference Call
  • March 4, 2008
  • February 28, 2008
  • February 20, 2008
  • February 13, 2008
  • February 6, 2008
  • 2007 Press Releases
Press Releases
Home » News/Events » Press Releases

Press Releases

June 19, 2008
DUSA Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference on June 26

May 16, 2008
DUSA Files Form S-3 Shelf Registration Statement

May 7, 2008
May 7, 2008 First Quarter 2008 Corporate Highlights and Financial Results Conference Call

May 7, 2008
DUSA Pharmaceuticals Reports First Quarter 2008 Corporate Highlights and Financial Results

May 2, 2008
DUSA Pharmaceuticals, Inc. to Host First Quarter Financial Results and Corporate Highlights Conference Call

May 1, 2008
Phase I Clinical Trial of Photodynamic Therapy (PDT) Underway for Potential New Treatment of Oral Precancerous Lesions

April 21, 2008
DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness

March 31, 2008
DUSA Completes Enrollment for Phase IIb Trial of LevulanĀ® Photodynamic Therapy for Moderate to Severe Acne

March 6, 2008
DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan PDT in Brazil

March 4, 2008
DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Corporate Highlights and Financial Results

< Previous 12 Next >

 

Customer Service | Reimbursement/Insurance Coverage
Careers | Legal Notice/Privacy Policy
© 2008, DUSA Pharmaceuticals, Inc.
All Rights Reserved.